Gabelli Funds’s Day One Biopharmaceuticals DAWN Stock Holding History

Gabelli Funds’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-464,097	Closed	-$9.95M	–	1306
2026 Q1	$9.95M	Buy	+464,097	New	+$6.54M	0.07%	332

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Gabelli Funds's DAWN Position: Q2 2026 in Review

Gabelli Funds sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 464,097 shares — an estimated $9.95M sold.

Gabelli Funds first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $9.95M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Gabelli Funds reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Gabelli Funds sold 464,097 Day One Biopharmaceuticals shares in Q2 2026, an estimated $9.95M.
Gabelli Funds first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
Gabelli Funds's Day One Biopharmaceuticals position peaked at $9.95M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.